LOS ANGELES, CA — (Marketwired) — 10/02/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that two additional patents will be granted for its B-cell vaccine technologies. MMR has been notified it will receive another U.S. patent protecting methods of making compositions for B-cell vaccines pursuant to a Notice of Allowance from the United States Patent and Trademark Office. The
LOS ANGELES, CA — (Marketwired) — 08/19/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that as a result of China-s participation in the Patent Prosecution Highway Program and the issuance of patents to MMR for its anti-CD20 monoclonal antibodies in the U.S., the Company has received confirmation from China of the filing on August 15, 2013 of a divisional Chinese patent appli
LOS ANGELES, CA — (Marketwired) — 04/15/13 — (OTCQB: MMRF) ("MMR") today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the Company-s anti-CD20 monoclonal antibody assets, U.S. Serial No. 11/855,943, under the title, "Antibodies and Methods for Making and Using Them." This is the first U.S. patent to be granted for the Company-s anti-CD20 monoclonal antibodies, which have particular utility in fighting cancers. The anti-
LOS ANGELES, CA — (Marketwire) — 11/19/12 — (OTCBB: MMRF) today announced that through its wholly owned subsidiary, MMR Life Sciences Group, the Company plans on exploiting its pipeline of biotech assets by facilitating a partnership or other joint venture with a privately held biotech company that has completed its Phase 2 clinical trials and is in the process of beginning Phase 3. The Company has held talks with several privately held biotech companies who are finding it difficult to get
LOS ANGELES, CA — (Marketwire) — 11/28/11 — (OTCBB: MMRF) () today announced that it has just been granted a patent protecting methods of making compositions for B-cell vaccines and will soon also have Notice of Allowance for another U.S. Patent protecting "Methods of treating a patient with a B-cell lymphoma." Although technically complex, the patent is a manufacturing patent that covers the methods of making compositions for B-cell vaccines used in the fight against lymphoma an
